- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Nuclear imagers adjust to to practice without Mo-99
Nuclear imagers are using alternatives to keep their practices alive until the National Research Universal Reactor at Chalk River, ON, resumes production of Mo-99
Nuclear imagers are using alternatives to keep their practices alive until the National Research Universal Reactor at Chalk River, ON, resumes production of Mo-99. The shutdown has disrupted 60% of radiopharmacies in the U.S., according to an online survey jointly sponsored by the SNM and the National Association of Nuclear Pharmacies.
Only a third of respondents said they have an alternate source of Mo-99/Tc-99m generators, namely manufacturers with access to isotopes produced in reactors outside of North America. About 84% have eluted older generators more often to draw off as much technetium isotope as possible; 82% are using thallium-201 for cardiac imaging; 6% are performing F-18 FDG-PET bone imaging; and about 9% have shifted to F-18 sodium fluoride (NaF). Indium-111 (5%), gallium-67 (2%), and nitrogen-14 ammonia (1%) were also cited as alternatives.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
